Critical evaluation of mixed treatment comparison meta-analyses using examples assessing antidepressants and opioid detoxification treatments

International Journal of Methods in Psychiatric Research

Volumn 22, Issue 2, 2013, Pages 166-174

  Schacht, Alexander ^a   Dyachkova, Yulia ^b   Walton, Richard James ^c  

^a LILLY DEUTSCHLAND GMBH   (Germany)

^b Eli Lilly Regional Operations   (Austria)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bias; Incoherence; Inconsistency; Mixed treatment comparison (MTC); Multiple treatment meta analysis

Indexed keywords

ANTIDEPRESSANT AGENT; NARCOTIC ANALGESIC AGENT;

ADDICTION; ARTICLE; DRUG DETOXIFICATION; HUMAN; META ANALYSIS (TOPIC); PHYSIOLOGY;

ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS; HUMANS; META-ANALYSIS AS TOPIC; METABOLIC DETOXICATION, DRUG; SUBSTANCE-RELATED DISORDERS;

EID: 84879500229     PISSN: 10498931     EISSN: 15570657     Source Type: Journal    
DOI: 10.1002/mpr.1381     Document Type: Article

References (29)

1. Ades A.E., Sutton A.J. (2006) Multiparameter evidence synthesis in epidemiologyand medical decision-making: current approaches. Journal of the Royal Statistical Society Series A, 169(Part 1), 5-35.
2. Baker S.G., Kramer B.S. (2002) The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C? BMC Medical Research Methodology, 2(1), 13.
3. Bucher H.C., Guyatt G.H., Griffith L.E., Walter S.D. (1997) The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology, 50(6), 683-691.
4. Caldwell D.M., Ades A.E., Higgins J.P.T. (2005) Simultaneous comparison of multiple treatments: combining direct and indirect evidence. British Medical Journal, 331, 897-900.
5. Chou R., Fu R., Huffman L.H., Korthuis P.T. (2006) Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses. Lancet, 368(9546), 1503-1515.
6. Cipriani A., Furukawa T.A., Salanti G., Geddes J.R., Higgins J.P., Churchill R., Watanabe N., Nakagawa A., Omori I.M., McGuire H., Tansella M., Barbui C. (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 373(9691), 746-758.
7. Deeks J.J. (2002) Issues on the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine, 21(11), 1575-1600.
8. Dias S., Welton N.J., Caldwell D.M., Ades A.E. (2010) Checking consistency in mixed treatment comparison meta-analysis. Statistics in Medicine, 29(7-8), 932-944.
9. Gartlehner G., Gaynes B.N., Hansen R.A., Thieda P., DeVeaugh-Geiss A., Krebs E.E., Moore C.G., Morgan L., Lohr K.N. (2008) Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Annals of Internal Medicine, 149(10), 734-750.
10. Goldstein D.J., Mallinckrodt C., Lu Y., Demitrack M.A. (2002) Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. The Journal of Clinical Psychiatry, 63(3), 225-231.
11. Higgins J.P.T. (2008) Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. International Journal of Epidemiology, 37(5), 1158-1160.
12. Higgins J.P.T, Green S. (eds) (2005) Cochrane handbook for systematic reviews of interventions. In Cochrane Library, Issue 2, Chichester, John Wiley & Sons.
13. Higgins J.P.T., Thompson S.G. (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539-1558.
14. Higgins J.P.T., White I.R., Wood A.M. (2008) Imputation methods for missing outcome data in meta-analysis of clinical trials. Clinical Trials, 5(3), 2250-2239.
15. Juni P., Altman D., Egger M. (1995) Assessing the quality of randomized controlled trials. In Egger M., Smith G.D., Altman D.G. (eds) Systematic Reviews, pp. 87-108, London, British Medical Journal.
16. Lu G., Ades A.E. (2004) Combination of direct and indirect evidence in mixed treatment comparisons. Statistics in Medicine, 23(20), 3105-3124.
17. Lumley T. (2002) Network meta-analysis for indirect treatment comparisons. Statistics in Medicine, 21(16), 2313-2324.
18. McPartlin G.M., Reynolds A., Anderson C., Casoy J. (1998) A comparison of once-daily venlafaxine XR and paroxetine in depressed outpatients treated in general practice. Primary Care Psychiatry, 4(3), 127-132.
19. Meader N. (2010) A comparison of methadone, buprenorphine and alpha2 adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis. Drug and Alcohol Dependence, 108(1), 110-114.
20. Rief W., Nestoriuc Y., Weiss S., Welzel E., Barsky A., Hofmann S. (2009) Meta-analysis of the placebo response in antidepressant trials. Journal of Affective Disorders, 118(1), 1-8.
21. Salanti G., Higgins J.P.T., Ades A.E., Ioannidis J.P.A. (2008) Evaluation of networks of randomized trials. Statistical Methods in Medical Research, 27(2), 279-301.
22. Senn S.J. (2000) The many modes of meta. Drug Information Journal, 34(2), 535-549.
23. Song F., Altman D.G., Glenny A.M., Deeks J.J. (2003) Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. British Medical Journal, 326(7387), 472-476.
24. Song F., Eastwood A.J., Gilbody S., Duley L., Sutton A.J. (2000) Publication and related biases. Health Technology Assessment, 4(10), 1-115.
25. Song F., Harvey I., Lilford R. (2008) Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. Journal of Clinical Epidemiology, 61(5), 455-463.
26. Song F., Loke Y.K., Walsh T., Glenny A.M., Eastwood A.J., Altman D.G. (2009) Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. British Medical Journal, 338(7700), b1147.
27. Sutton A., Ades A.E., Cooper N., Abrams K. (2008) Use of indirect and mixed treatment comparisons for technology assessment. PharmacoEconomics, 26(9), 753-767.
28. Sutton A.J., Higgins J.P.T. (2008) Recent developments in meta-analysis. Statistics in Medicine, 27(5), 625-50.
29. Victor N. (1995) The challenge of meta-analysis: discussion. Indications and contra-indications for meta-analysis. Journal of Clinical Epidemiology, 1(1), 5-8.